These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37728541)

  • 21. Empirical ways to identify novel Bedaquiline resistance mutations in AtpE.
    Karmakar M; Rodrigues CHM; Holt KE; Dunstan SJ; Denholm J; Ascher DB
    PLoS One; 2019; 14(5):e0217169. PubMed ID: 31141524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis.
    An Q; Lin R; Yang Q; Wang C; Wang D
    J Glob Antimicrob Resist; 2023 Sep; 34():214-226. PubMed ID: 37172764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
    Peretokina IV; Krylova LY; Antonova OV; Kholina MS; Kulagina EV; Nosova EY; Safonova SG; Borisov SE; Zimenkov DV
    J Infect; 2020 May; 80(5):527-535. PubMed ID: 31981638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi, China.
    Yang J; Pang Y; Zhang T; Xian X; Li Y; Wang R; Wang P; Zhang M; Wang J
    Int J Infect Dis; 2020 Oct; 99():163-170. PubMed ID: 32738481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study.
    Derendinger B; Dippenaar A; de Vos M; Huo S; Alberts R; Tadokera R; Limberis J; Sirgel F; Dolby T; Spies C; Reuter A; Folkerts M; Allender C; Lemmer D; Van Rie A; Gagneux S; Rigouts L; Te Riele J; Dheda K; Engelthaler DM; Warren R; Metcalfe J; Cox H; Theron G
    Lancet Microbe; 2023 Dec; 4(12):e972-e982. PubMed ID: 37931638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
    Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
    Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations.
    Otum CC; Rivière E; Barnard M; Loubser J; Williams MJ; Streicher EM; Van Rie A; Warren RM; Klopper M
    Sci Rep; 2023 Jun; 13(1):9212. PubMed ID: 37280265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in
    Ismail N; Omar SV; Ismail NA; Peters RPH
    Data Brief; 2018 Oct; 20():1975-1983. PubMed ID: 30306102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
    Salifu EY; Agoni C; Olotu FA; Soliman MES
    Comput Biol Chem; 2020 Apr; 85():107204. PubMed ID: 31981966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    Zimenkov DV; Nosova EY; Kulagina EV; Antonova OV; Arslanbaeva LR; Isakova AI; Krylova LY; Peretokina IV; Makarova MV; Safonova SG; Borisov SE; Gryadunov DA
    J Antimicrob Chemother; 2017 Jul; 72(7):1901-1906. PubMed ID: 28387862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
    Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Ismail N; Ismail NA; Omar SV; Peters RPH
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.
    Kadura S; King N; Nakhoul M; Zhu H; Theron G; Köser CU; Farhat M
    J Antimicrob Chemother; 2020 Aug; 75(8):2031-2043. PubMed ID: 32361756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced Susceptibility of Mycobacterium tuberculosis to Bedaquiline During Antituberculosis Treatment and Its Correlation With Clinical Outcomes in China.
    Liu Y; Gao M; Du J; Wang L; Gao J; Shu W; Wang Y; Xue Z; Li L; Pang Y
    Clin Infect Dis; 2021 Nov; 73(9):e3391-e3397. PubMed ID: 32667984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention.
    Nguyen TVA; Anthony RM; Bañuls AL; Nguyen TVA; Vu DH; Alffenaar JC
    Clin Infect Dis; 2018 May; 66(10):1625-1630. PubMed ID: 29126225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation in
    Singh BK; Soneja M; Sharma R; Chaubey J; Kodan P; Jorwal P; Nischal N; Chandra S; Ramachandran R; Wig N
    Int J Mycobacteriol; 2020; 9(2):212-215. PubMed ID: 32474547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.
    Battaglia S; Spitaleri A; Cabibbe AM; Meehan CJ; Utpatel C; Ismail N; Tahseen S; Skrahina A; Alikhanova N; Mostofa Kamal SM; Barbova A; Niemann S; Groenheit R; Dean AS; Zignol M; Rigouts L; Cirillo DM
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32907992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China.
    Hu Y; Fan J; Zhu D; Liu W; Li F; Li T; Zheng H
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):19. PubMed ID: 36855179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure.
    Le Ray LF; Aubry A; Sougakoff W; Revest M; Robert J; Bonnet I; Veziris N; Morel F
    Emerg Infect Dis; 2022 May; 28(5):1062-1064. PubMed ID: 35447056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant
    Almeida D; Converse PJ; Li SY; Upton AM; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0141221. PubMed ID: 34570644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.